National Health Investors, Inc. $NHI Shares Sold by Engineers Gate Manager LP

Key Points

• Engineers Gate Manager LP cut its National Health Investors position by 35.7% in the second quarter, selling 22,851 shares and retaining 41,155 shares valued at approximately $3.14 million. Institutional investors collectively own 62.51% of NHI.
• Analyst sentiment remains broadly positive, with a consensus rating of “Moderate Buy” and an average price target of $82.25, despite several recent price-target reductions and one “strong sell” rating.
• NHI shares opened at $70.43, below the consensus target, while the company reported quarterly EPS of $1.19 and revenue of $121.32 million. It also declared a quarterly dividend of $0.92 per share, equating to a 5.2% yield.

Engineers Gate Manager LP reduced its position in National Health Investors, Inc. (NYSE:NHI - Free Report) by 35.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 41,155 shares of the real estate investment trust's stock after selling 22,851 shares during the period. Engineers Gate Manager LP owned approximately 0.08% of National Health Investors worth $3,138,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. International Assets Investment Management LLC acquired a new position in National Health Investors during the 4th quarter worth approximately $27,000. EverSource Wealth Advisors LLC increased its position in shares of National Health Investors by 244.1% during the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust's stock worth $28,000 after acquiring an additional 288 shares during the last quarter. Garton & Associates Financial Advisors LLC acquired a new position in shares of National Health Investors in the 4th quarter valued at approximately $33,000. Allworth Financial LP bought a new position in National Health Investors during the 2nd quarter valued at $42,000. Finally, Advisory Services Network LLC bought a new position in shares of National Health Investors during the third quarter worth about $65,000. Institutional investors and hedge funds own 62.51% of the company's stock.

Wall Street Analysts Forecast Growth

NHI has been the subject of a number of research reports. Zacks Research downgraded shares of National Health Investors from a "hold" rating to a "strong sell" rating in a report on Thursday, June 25th. Truist Financial dropped their price target on shares of National Health Investors from $81.00 to $80.00 and set a "buy" rating on the stock in a research report on Wednesday, September 2nd. National Bank Financial set a $79.00 price target on National Health Investors in a research note on Wednesday. Wells Fargo & Company lowered their price target on National Health Investors from $79.00 to $78.00 and set an "equal weight" rating on the stock in a research report on Tuesday, September 1st. Finally, Deutsche Bank Aktiengesellschaft dropped their price objective on National Health Investors from $85.00 to $80.00 and set a "hold" rating on the stock in a research note on Thursday, June 25th. Six research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $82.25.

National Health Investors Stock Up 0.2%

NYSE:NHI opened at $70.43 on Monday. The business's fifty day moving average price is $74.73 and its 200 day moving average price is $77.46. The company has a current ratio of 6.78, a quick ratio of 6.78 and a debt-to-equity ratio of 0.81. The firm has a market capitalization of $3.46 billion, a price-to-earnings ratio of 20.36, a PEG ratio of 3.75 and a beta of 0.52. National Health Investors, Inc. has a 1-year low of $67.94 and a 1-year high of $91.38.

National Health Investors (NYSE:NHI - Get Free Report) last posted its quarterly earnings results on Monday, August 10th. The real estate investment trust reported $1.19 EPS for the quarter. The business had revenue of $121.32 million during the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. The business's revenue for the quarter was up 1.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.22 earnings per share. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. On average, sell-side analysts forecast that National Health Investors, Inc. will post 4.76 earnings per share for the current fiscal year.

National Health Investors Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 6th. Stockholders of record on Wednesday, September 30th will be issued a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a dividend yield of 5.2%. The ex-dividend date is Wednesday, September 30th. National Health Investors's payout ratio is currently 106.36%.

National Health Investors Profile

National Health Investors, Inc NYSE: NHI is a real estate investment trust that owns and finances healthcare real estate. The company focuses primarily on properties serving older adults and patients requiring specialized care, including independent living, assisted living, memory care, skilled nursing and continuing care retirement communities.

NHI generally leases its properties to healthcare and senior-living operators under long-term agreements, including primarily triple-net leases, under which tenants are typically responsible for property-level operating expenses, maintenance and taxes.

Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.